|
Volumn 52, Issue 5, 2004, Pages 845-
|
Donepezil delay to nursing home placement study is flawed.
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CHOLINESTERASE INHIBITOR;
DONEPEZIL;
INDAN DERIVATIVE;
NOOTROPIC AGENT;
PIPERIDINE DERIVATIVE;
ALZHEIMER DISEASE;
CAREGIVER;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
HUMAN;
INSTITUTIONALIZATION;
MORTALITY;
NOTE;
NURSING HOME;
RANDOMIZED CONTROLLED TRIAL;
RESEARCH;
TIME;
TREATMENT OUTCOME;
ALZHEIMER DISEASE;
CAREGIVERS;
CHOLINESTERASE INHIBITORS;
CONTROLLED CLINICAL TRIALS;
HUMANS;
INDANS;
INSTITUTIONALIZATION;
NOOTROPIC AGENTS;
NURSING HOMES;
PIPERIDINES;
RANDOMIZED CONTROLLED TRIALS;
RESEARCH;
TIME FACTORS;
TREATMENT OUTCOME;
|
EID: 2542484565
PISSN: 00028614
EISSN: None
Source Type: Journal
DOI: 10.1111/j.1532-5415.2004.52230_3.x Document Type: Note |
Times cited : (16)
|
References (0)
|